Patent and Trademark Office

Comscore Awarded New US Patent for Household Device Identification

Retrieved on: 
Wednesday, September 16, 2020
Intellectual property law, Patent offices, comScore, United States Patent and Trademark Office, Patent and Trademark Office, United States patent law

RESTON, Va., Sept. 16, 2020 /PRNewswire/ -- Comscore (NASDAQ: SCOR), a trusted partner for planning, transacting, and evaluating media across platforms, is proud to announce that the US Patent and Trademark Office (USPTO) has granted its patent on "Device Identification System and Methods."

Key Points: 
  • RESTON, Va., Sept. 16, 2020 /PRNewswire/ -- Comscore (NASDAQ: SCOR), a trusted partner for planning, transacting, and evaluating media across platforms, is proud to announce that the US Patent and Trademark Office (USPTO) has granted its patent on "Device Identification System and Methods."
  • This patent, which was accepted by the USPTO on the very first round, covers Comscore's method of using household router meters to anonymously identify individuals within a household.
  • The invention will enable Comscore to draw even more precise, granular insights into consumer behavior for its best-in-class digital and cross-platform measurement.
  • Comscore's continued commitment to research and innovation is reflected by the numerous U.S. patents it has been granted over the last five years, including a recent patent for device co-location identification.

Alligator Bioscience receives patent approval for the drug candidate ATOR-1015

Retrieved on: 
Wednesday, September 16, 2020
Intellectual property law, Immunology, Patent and Trademark Office, Antibody, Cancer immunotherapy, Branches of biology, Medicine

LUND, Sweden, Sept. 16, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX)announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.

Key Points: 
  • LUND, Sweden, Sept. 16, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX)announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.
  • 10,774,150 which covers compositions of matter directed to Alligator's bispecific drug candidate ATOR-1015.
  • This is now protected by a granted US patent," commented Per Norln, CEO at Alligator Bioscience.
  • Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs.

Alligator Bioscience receives patent approval for the drug candidate ATOR-1015

Retrieved on: 
Wednesday, September 16, 2020
Intellectual property law, Immunology, Patent and Trademark Office, Antibody, Cancer immunotherapy, Branches of biology, Medicine

LUND, Sweden, Sept. 16, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX)announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.

Key Points: 
  • LUND, Sweden, Sept. 16, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX)announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.
  • 10,774,150 which covers compositions of matter directed to Alligator's bispecific drug candidate ATOR-1015.
  • This is now protected by a granted US patent," commented Per Norln, CEO at Alligator Bioscience.
  • Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs.

USPTO Issues OTT Pause Ad Patent to Black-Owned Pause Commercials Inc.

Retrieved on: 
Monday, September 14, 2020
Intellectual property law, Intellectual property organizations, Patent and Trademark Office, United States patent law, Trademark, Marketing

LOS ANGELES, Sept. 14, 2020 /PRNewswire/ -- Pause Commercials , ("PUCs") announced this week that the United States Patent and Trademark Office (USPTO) has issued a patent [U.S. Patent #10728619 ("the '619 Patent") - Application Serial #16228607] relating to their proprietary process technology for pause ads in the over-the-top (OTT) media space.

Key Points: 
  • LOS ANGELES, Sept. 14, 2020 /PRNewswire/ -- Pause Commercials , ("PUCs") announced this week that the United States Patent and Trademark Office (USPTO) has issued a patent [U.S. Patent #10728619 ("the '619 Patent") - Application Serial #16228607] relating to their proprietary process technology for pause ads in the over-the-top (OTT) media space.
  • Effective July 28, 2020, the '619' Patent covers the method of delivering video and display ads, as well as making transactions, when users pause any device in OTT.
  • Simply defined, PUCs delivers non-disruptive, non-intrusive, user-initiated relevant ad experiences to consumers when the pause button is pushed.
  • Collectively, their professional backgrounds tackle technical and social issues throughout ad tech, Hollywood, Silicon Valley, and Madison Avenue.

DGAP-News: Schaeffler AG: Schaeffler accelerates transformation and strengthens competitiveness

Retrieved on: 
Wednesday, September 9, 2020
German patent law, Schaeffler Group, Deutsches Patent- und Markenamt, Patent and Trademark Office, DPMA, Schaeffler, Patent, Motorola, Companies, Business, Industries

The automotive industry, which was already undergoing structural transformation amid the move to electrification, has been hit hard by the COVID-19 crisis.

Key Points: 
  • The automotive industry, which was already undergoing structural transformation amid the move to electrification, has been hit hard by the COVID-19 crisis.
  • The second is to strengthen the company's competitiveness and build up local capabilities at selected locations in Germany.
  • We're a family business, so we know just how vital that is to achieving successful change and transformation at Schaeffler."
  • With almost 2,400 patent applications in 2019, Schaeffler is Germany's second most innovative company according to the DPMA (German Patent and Trademark Office).

UVision360 Announces Publication of Novel Biopsy Patent for the LUMINELLE® DTx System

Retrieved on: 
Tuesday, September 1, 2020
Intellectual property law, Patent offices, Biopsy, Interventional radiology, United States Patent and Trademark Office, Patent and Trademark Office

The United States Patent and Trademark Office (USPTO) has issued patent 10,758,214 titled "BIOPSY DEVICE AND METHOD."

Key Points: 
  • The United States Patent and Trademark Office (USPTO) has issued patent 10,758,214 titled "BIOPSY DEVICE AND METHOD."
  • The allowed claims cover the novel biopsy sleeve, biopsy system which allows for visualization, and a method of collecting a biopsy sample.
  • "With procedures moving out of the hospital and into the gynecologist's office, this patent further protects the uniqueness of the LUMINELLE System," said Allison London Brown, CEO of UVision360.
  • The company has created the LUMINELLE DTx System, a simplified, compact and modular endoscopic system employing the latest in high-tech optics and interchangeable accessories to meet the needs of physicians and patients.

Fuze Harnesses Machine Learning in New Patent for Distributing Communication Requests

Retrieved on: 
Monday, August 24, 2020
Data management, Technology, Other Communications, Communications, Other Technology, Telecommunications, Networks, Audio, Video, Internet, VoIP, Mobile, Wireless, Intellectual property law, Fuze, Teleconferencing, Videotelephony, Telecommunications, Intellectual property organizations, Patent offices, United States Patent and Trademark Office, United States patent law, Patent and Trademark Office

Fuze , the leading cloud-based communications provider for the modern global enterprise, today announced that it has been awarded a new patent for distributing communication requests using machine learning (ML), enabling more efficient communications for Fuze users and their customers.

Key Points: 
  • Fuze , the leading cloud-based communications provider for the modern global enterprise, today announced that it has been awarded a new patent for distributing communication requests using machine learning (ML), enabling more efficient communications for Fuze users and their customers.
  • The U.S. Patent and Trademark Office (USPTO) issued Fuze U.S. Patent No.
  • The invention uses machine learning to analyze live user data and historical communication patterns to inform predictive models that can quickly direct incoming communication requests from customers or internal employees.
  • As the distributed workforce grows, facilitating meaningful communication experiences becomes increasingly complex, requiring more advanced technology, said Rob Scudiere, president and chief operating officer at Fuze.

Motus GI Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, August 11, 2020
Intellectual property law, International Searching and Preliminary Examining Authorities, Patent offices, Motus, United States Patent and Trademark Office, Patent and Trademark Office, Geisinger

During this time, Motus GI has placed the Pure-Vu System in more than 20 of these targeted hospitals.

Key Points: 
  • During this time, Motus GI has placed the Pure-Vu System in more than 20 of these targeted hospitals.
  • In the second quarter, the Company initiated new Pure-Vu evaluations at UC-Irvine Health, Sinai Hospital Baltimore, Memorial Hermann and Geisinger Medical Center.
  • In the second quarter of 2020, the Company received notice that the U.S. Patent and Trademark Office (USPTO) issued patent No.
  • As part of this effort, in late-May we launched a new mobile Motus GI APP that provides a plethora of valuable resources for Pure-Vu System users.

American Energy Partners Subsidiary Awarded U.S. Patent

Retrieved on: 
Tuesday, August 4, 2020
Intellectual property law, Monopoly, Intellectual property organizations, Patent and Trademark Office, Hydration, Patent

ALLENTOWN, PA, Aug. 04, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --American Energy Partners, Inc.(American Energy) (PINK: AEPT), a diversified energy company, announces that its subsidiary Hydration Company of PA, LLC (Hydration) has been awarded a utility patent from the U.S. Patent and Trademark Office (USPTO).

Key Points: 
  • ALLENTOWN, PA, Aug. 04, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --American Energy Partners, Inc.(American Energy) (PINK: AEPT), a diversified energy company, announces that its subsidiary Hydration Company of PA, LLC (Hydration) has been awarded a utility patent from the U.S. Patent and Trademark Office (USPTO).
  • American Energy, parent to Hydration, has retained the accounting and consulting firm Grossman Yanak & Ford, LLP.
  • The firm specializes in the valuation of intellectual property and we expect to receive a valuation on the patent prior to Q4 20.
  • Brad Domitrovitsch, Chairman & CEO of American Energy, stated, After several years of hard work we have received a patent that further validates Hydrations business model.

Guardian Alliance Technologies DENIED Again by USPTO Judges in Attempt to Invalidate Miller Mendel's eSOPH Patent

Retrieved on: 
Monday, August 3, 2020
Intellectual property law, United States patent law, PTAB, Patent Trial and Appeal Board, Inter partes review, Patent and Trademark Office

WASHINGTON, Aug. 3, 2020 /PRNewswire/ -- The United States Patent and Trademark Office (USPTO), Patent Trial and Appeal Board (PTAB) has again, for the second time, DENIED Guardian Alliance Technologies' attempt to invalidate Miller Mendel's 188 Patent.

Key Points: 
  • WASHINGTON, Aug. 3, 2020 /PRNewswire/ -- The United States Patent and Trademark Office (USPTO), Patent Trial and Appeal Board (PTAB) has again, for the second time, DENIED Guardian Alliance Technologies' attempt to invalidate Miller Mendel's 188 Patent.
  • Miller Mendel, Inc. asserted in a federal lawsuit filedOctober 9, 2018, that Guardian Alliance Technologies' platform infringes on certain claims in Miller Mendel's 188 patent.
  • The patent was granted to Tyler Miller, Miller Mendel's Founder, President and CEO onJune 30, 2015, and licensed exclusively to Miller Mendel, Inc.
  • OnMarch 26, 2020, the USPTO PTAB judges issued a 22-page decision , denying Guardian Alliance Technologies' Inter Partes Review request.